Bristol Myers Squibb Company

Winter and the Holidays are right around the corner, but don’t stop your job search! Check out the top companies who are looking for candidates like you right now!

Many of these directors do not publicly disclose their affiliation with the pharma companies in their nonprofit biographies, report shows.

Bristol-Myers Squibb is teaming up with Cancer Research UK and the Francis Crick Institute to create guidelines for immuno-oncology therapy development. This “rule book,” will focus on lung cancer treatments.

Bristol-Myers Squibb and LabCentral, a Cambridge, Mass.-based shared laboratory space, announced the two winners of the Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral. Due to being a platinum sponsor, Bristol-Myers Squibb could choose up to two innovative life science companies per year for Golden Tickets. This covers the cost of one lab bench for one year at LabCentral’s facility at Kendall Square in Cambridge.

Joseph Eid, head of medical at BMS, said Empliciti in combination with pomalidomide and dexamethasone has provided proof that the medication can extend the time a patient can live without the worsening of his or her disease.

According to the American Cancer Society, almost 601,000 people in the U.S. died of cancer in 2017. The two most common types of cancer are lung cancer and breast cancer, followed by colorectal cancer, prostate cancer and stomach cancer.

Fall is in full swing, but not falling short of jobs. Check out the top companies who are looking for candidates like you right now!

Mesothelioma is a rare cancer that develops in the lining of the lungs, abdomen, or cardiovascular cavity. A 2017 study reported that the number of people affected by this rare cancer is between 2,400 - 2,800 individuals per year in the United States alone.

A combination of Opdivo and Yervoy yielded a significantly longer treatment-free survival period for patients with previously untreated advanced or metastatic renal cell carcinoma (RCC) than patients who were treated with sunitinib, the standard of care.